This experimental setup validated photoplethysmography devices for monitoring arteriovenous fistulas, implying enhanced patient safety.
This study describes the design and validation of an experimental setup for testing photoplethysmographic (PPG) devices intended for the non-invasive monitoring of vascular accesses in hemodialysis patients. Continuous assessment of arteriovenous fistulas is essential to detect pathological conditions such as stenosis, which can compromise patient safety and dialysis efficacy. While PPG-based sensors are capable of detecting such anomalies, their clinical applicability must be supported by controlled in vitro validation. The developed system replicates the anatomical, mechanical, optical, and hemodynamic features of vascular accesses. A 3D fistula model was designed and fabricated via 3D printing and silicone casting. The hydraulic circuit used red India ink and a PWM-controlled pump to simulate physiological blood flow, including stenotic conditions. Quantitative validation confirmed anatomical accuracy within 0.1 mm tolerance. The phantom exhibited an average Shore A hardness of 20.3 ± 1.1, a Young’s modulus of 10.4 ± 0.9 MPa, and a compression modulus of 105 MPa—values consistent with soft tissue behavior. Burst pressure exceeded 2000 mmHg, meeting ISO 7198:2016 standards. Flow rates (400–700 mL/min) showed <1% error. Compliance was 2.4 ± 0.2, and simulated blood viscosity was 3.9 ± 0.3 mPa·s. Systolic and diastolic pressures fell within physiological ranges. Photoplethysmographic signals acquired using a MAX30102 sensor (Analog devices Inc., Wilmington, MA, USA) reproduced key components of in vivo waveforms, confirming the system’s suitability for device testing.
No takes yet. Share an insight, caveat, or question.
Chiorboli et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: